February 06,2008
Sen. Grassley’s letter regarding the FDA, a pharmaceutical drug maker and a safety officer at the FDA
Please view the printer-friendly version of Senator Grassley’s letter regarding the FDA, a pharmaceutical drug maker and a safety officer at the FDA.
Next Article Previous Article
Recent News
- Crapo Statement at Hearing on the President’s 2024 Trade Policy Agenda
- Crapo Statement at Hearing on IRS FY 2025 Budget and 2024 Filing Season
- Crapo Statement at Hearing on Medicare Clinician Payment Improvements
- Crapo Blasts President’s Budget: “Higher Taxes for the Majority to Support Government Subsidies for the Few”
- Crapo Statement at Hearing on President’s FY 2025 Budget